Key result
Second-generation drug-eluting stents demonstrated similar 2-week vascular responses, including >90% strut coverage and comparable intra-stent thrombus, compared to bare-metal stents in patients with STEMI.
Why the study?
Do second-generation drug-eluting stents compared to bare-metal stents alter early phase arterial reaction and intra-stent thrombus formation at 2 weeks in patients with STEMI?
Observational (n=24)
Single-blind
Yes
Do second-generation drug-eluting stents compared to bare-metal stents alter early phase arterial reaction and intra-stent thrombus formation at 2 weeks in patients with STEMI?
Answers are grounded in this paper and cite their sources.
Comparable early healing with second-generation DES and BMS in STEMI; hypothesis-generating and should not yet change practice.
The early phase arterial reaction after implantation of second-generation drug-eluting stents (2nd DES) and baremetal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear.The MECHANISM pilot study is a multi-center prospective registry that enrolled 24 STEMI patients (from 11 centers) who had undergone implantation of everolimus-eluting (n = 6), biolimus A9-eluting (n = 6) or zotarolimus-eluting stents (n = 6), or BMS (n = 6). Scheduled optical coherence tomography (OCT) was performed 2 weeks after implantation, and images were independently analyzed at a core laboratory in a blinded fashion. Intra-stent thrombus was quantitatively analyzed in terms of the maximal area and the percentage of cross-sections with thrombus (the numbers of cross-section with thrombus × 100 divided by total number of cross-sections within the stented segment). More than 90% of struts were already covered 2 weeks after the index procedure, regardless of the stent type. There were no differences in stent diameter, minimal lumen diameter, minimal lumen area, neointimal thickness, or the frequencies of malapposed and uncovered struts among the 4 groups. The quantity of intra-stent thrombus also did not differ among the 4 groups.The results of this pilot study suggest that the 2-week vascular responses seem to be similar among 2nd DES and BMS in STEMI patients. Considering the possible advantage of 2nd DES in the prevention of restenosis, 2nd DES are a feasible option for the treatment of patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Nishio et al. (2015) conducted an observational in ST-Segment Elevation Myocardial Infarction (n=24). Second-generation drug-eluting stents (EES, BES, ZES) vs. Bare-metal stents (BMS) was evaluated on Percentage of covered struts at 2 weeks (p=0.40). Second-generation drug-eluting stents demonstrated similar 2-week vascular responses, including >90% strut coverage and comparable intra-stent thrombus, compared to bare-metal stents in patients with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: